Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreases in influenza vaccination coverage among nursing home healthcare workers and in measures to promote influenza vaccination, France, 2007/08 to 2024/25.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Factors associated with an unfavorable outcome according to age in patients with COVID-19 admitted to intensive care in mainland France during the first three periods of the pandemic: a nationwide cohort study.

Frontiers in medicine·2026
Same author

Investigation of a measles outbreak in a highly vaccinated middle school, France, 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same author

Modelling the impact of a quadrivalent ACWY meningococcal vaccination and vaccination targeting serogroup B in France.

Vaccine·2025
Same author

Increase in invasive Haemophilus influenzae type b disease in young children despite high vaccination coverage, France, 2018-2024.

Vaccine·2025
Same author

High incidence of pneumonia cases observed in children seen in general practice consultations during the 2023-2024 season, France.

Pneumonia (Nathan Qld.)·2025

Related Experiment Video

Updated: May 16, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

[Measles in France].

Denise Antona1, Claire Baudon, François Freymuth

  • 1Institut de veille sanitaire, St Maurice Cedex, France. d.antona@invs.sante.fr

Medecine Sciences : M/S
|November 23, 2012
PubMed
Summary

France reported over 22,000 measles cases from 2008-2012, with young adults highly affected. Improving vaccination coverage in this group is critical to prevent outbreaks and protect vulnerable populations.

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

Related Experiment Videos

Last Updated: May 16, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Measles outbreaks pose a significant public health risk, particularly in populations with suboptimal vaccination coverage.
  • France experienced a substantial measles burden between 2008 and 2012, highlighting ongoing challenges in disease control.

Purpose of the Study:

  • To analyze the epidemiology of measles cases reported in France between January 2008 and May 2012.
  • To identify key demographic groups affected by measles and understand the contributing factors to disease circulation.
  • To inform strategies for achieving measles elimination targets.

Main Methods:

  • Retrospective analysis of measles case reports from January 2008 to May 2012.
  • Calculation of incidence rates across different age groups.
  • Assessment of vaccination coverage and its impact on measles transmission.

Main Results:

  • Over 22,000 measles cases were reported, with the highest incidence in infants and over 50% in young adults.
  • Nearly 5,000 hospitalizations occurred, including severe complications like pneumonia and encephalitis, with 10 deaths.
  • Insufficient and uneven vaccination coverage facilitated measles virus circulation.

Conclusions:

  • Despite improved childhood vaccination rates, a critical gap remains in achieving adequate measles immunity among young adults.
  • Targeted vaccination campaigns for susceptible young adults are essential to interrupt measles transmission and protect vulnerable individuals.
  • Achieving measles elimination requires sustained efforts to address vaccination coverage disparities and maintain herd immunity.